Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Methotrexate Gel vs Clobetasol in Mild-Moderate Plaque Psoriasis
NCT06555497Phase 1Completed
- Sponsor
- Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium
- Start
- Jan 2022
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, triple-blind trial of methotrexate in plaque psoriasis (2 arms), sponsored by Dr. Jose N. Rodriguez Memorial Hospital and Sanitarium. Primary endpoints: Psoriasis Area and Severity Index at 8 weeks and Body Surface Area at 8 weeks. Started Jan 2022; status: completed.
02
Drugs
methotrexate
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT06555497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06555497.